{"url_path":"/sec/pmi/8-k/2026-05-21/item-2-02","section_key":"item-2-02","section_title":"Item 2.02 ****Results of Operations and","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-21","source_url":"https://www.sec.gov/Archives/edgar/data/2030617/0001829126-26-005568-index.html","accession_number":"0001829126-26-005568","cik":"0002030617","ticker":"PMI","issuer_name":"Picard Medical, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/2030617/0001829126-26-005568-index.html","primary_entity_key":"0002030617","primary_entity_name":"Picard Medical, Inc."},"word_count":126,"has_tables":true,"body_markdown":"**Item 2.02.****Results of Operations and\nFinancial Condition.**\n\n \n\nThe following information is intended to be furnished under Item 2.02\nof Form 8-K, “Results of Operations and Financial Condition.” This information shall not be deemed “filed” for\npurposes of Section 18 of the Securities Exchange Act of 1934, (the “Exchange Act”), or incorporated by reference in any filing\nunder the Securities Act of 1933 or the Exchange Act, whether made before or after the date of this report, regardless of any general\nincorporation language in the filing. In a press release dated May 21, 2026, Picard Medical, Inc. (the “Company”) announced\nfinancial results for the Company’s first quarter ended March 31, 2026. The full text of the press release is furnished herewith\nas Exhibit 99.1 to this report."}